Le Lézard
Classified in: Health, Science and technology
Subjects: Conference, Trade Show, Webcast

Acadia Pharmaceuticals to Participate at Upcoming Investor Conferences


Acadia Pharmaceuticals Inc. (Nasdaq: ACAD) today announced that it will participate at three upcoming investor conferences:

Citizens JMP Life Sciences Conference
Fireside Chat: Tuesday, May 14, 2024 at 1:30 p.m. Eastern Time in New York, NY

2024 RBC Capital Markets Global Healthcare Conference
Fireside Chat: Wednesday, May 15, 2024 at 11:30 a.m. Eastern Time in New York, NY

BofA Securities Health Care Conference
Fireside Chat: Wednesday, May 16, 2024 at 12:20 p.m. Eastern Time in Las Vegas, NV

Live webcasts of each fireside chat will be accessible on the company's website, Acadia.com, under the investors section and an archived recording will be available on the website for approximately one month following each presentation.

About Acadia Pharmaceuticals

Acadia is advancing breakthroughs in neuroscience to elevate life. For 30 years we have been working at the forefront of healthcare to bring vital solutions to people who need them most. We developed and commercialized the first and only FDA-approved drug to treat hallucinations and delusions associated with Parkinson's disease psychosis and the first and only FDA-approved drug for the treatment of Rett syndrome. Our clinical-stage development efforts are focused on Prader-Willi syndrome, Alzheimer's disease psychosis and multiple other programs targeting neuropsychiatric symptoms in central nervous system disorders. For more information, visit us at Acadia.com and follow us on LinkedIn and Twitter.


These press releases may also interest you

at 09:00
Helius Medical Technologies, Inc. Announces PoNS® Is Now Available on the Veterans Affairs (VA) Federal Supply Schedule (FSS) and General Services Administration (GSA) Advantage Contracts
Helius Medical Technologies, Inc. ("Helius" or the "Company"), a neurotech company focused on delivering a novel therapeutic neuromodulation approach for balance and gait deficits,...

at 08:55
Syra Health Wins Contract to Provide Special Education Psychologist Services for the Greenville County School District in South Carolina
Syra Health Corp. ("Syra Health" or the "Company"), a healthcare technology company with a mission to improve healthcare by providing innovative services and technology solutions, announced today that it has been awarded a one-year contract with...

at 08:47
5TH LIFE-CHANGING MEDICAL MISSION OF THE CANADA UKRAINE SURGICAL AID PROGRAM (CUSAP) HAS TAKEN PLACE IN POLAND APRIL 20 - MAY 8
The Canada Ukraine Surgical Aid Program (CUSAP), a joint initiative of the Canada-Ukraine Foundation (CUF) and the Sunnybrook Health Sciences Centre, has finished its fifth surgical mission in Czelad?, Poland. The team of 64 Canadian volunteers (only...

at 08:41
Advocate Rights Center Launches Guide for Bard PowerPort Leads, Marketing, and Intake
In an effort to assist mass tort law firms connect with victims of allegedly dangerous Bard port catheters, Advocate Rights Center proudly announces the release of a groundbreaking guide tailored for mass tort intake call center agents and marketers:...

at 08:38
Regen Wellness Announces Microneedling as a More Natural Skin Treatment
Regen Wellness is proud to announce they now offer the healthy skin rejuvenation of microneedling. Microneedling has quickly gained popularity as a natural and effective option for skin rejuvenation. This minimally invasive procedure involves using a...

at 08:35
Evolus Announces Positive Data from Pivotal Trial for First Two Evolyssetm Dermal Filler Products at 2024 SCALE Meeting
Evolus, Inc. , a performance beauty company with a focus on building an aesthetic portfolio of consumer brands, today announced positive topline results from a U.S. pivotal nasolabial fold (NLF) study of dermal filler products Evolyssetm Lift and...

More news about Health...


News published on and distributed by: